Drug discovery > Basic Research Products & Reviews

The first image-enabled spectral cell sorter

Spend Less Time Optimizing Panels and More Time Discovering

Help maximize your microbiology laboratory efficiencies

Siemens Healthineers offers the ELF test to help improve the assessment of NAFLD/NASH and chronic liver disease patients at risk of disease progression.

Monitor the effectiveness of TNF alpha inhibitors adalimumab, infliximab, and etanercept with one automated, cost-effective, and easily accessible assay.

Biograph™ TruePoint™ PET•CTThe World's First HD•PET PlatformSiemens Biograph™ is a flexible, high-powered medical imaging platform. It offers an wide range of performance options to enhance image resolution and quality, improve patient satisfaction as well as throughput. Customize the Biograph™ solution to meet your specific needs by selecting from various multislice CT configurations, high or standard resolution options, and…

CN Bio supports non-alcoholic steatohepatitis (NASH) therapeutic development via fast-track NASH Contract Research Services. NASH Services enable you to gain instant access to CN Bio’s expertise and one of the most advanced human in vitro models available. Submit lead candidates for screening and receive human translatable data for insightful preclinical candidate prioritization, clinical trial design and optimization.

Multi-chip Liver-12 consumable plates from CN Bio enable the advanced culture of 12 human 3D liver microtissues under perfusion/plate. Each microtissue recapitulates the functionality and microarchitecture of the human liver to accurately predict drug responses.

Multi-chip Barrier (MPS-T12) consumable Plates from CN Bio are used to culture advanced in vitro barrier models under perfusion, such as gut-on-a-chip or lung-on-a-chip, to predict human drug responses more accurately.